AI pushes retinal care into the wild
2026-09-07
AI in retinal care is no longer a lab curiosity; it is starting to behave like infrastructure. A new 3D optical coherence tomography foundation model sits at the center of this shift, trained across large volumetric datasets so that segmentation, fluid quantification and layer boundary detection become shared capabilities rather than bespoke code for each disease label.
More disruptive is the way vascular detail is being standardized. A broad review of optical coherence tomography angiography biomarkers argues that metrics such as foveal avascular zone area, vessel density and perfusion density can serve as common currency across diabetic retinopathy, age‑related macular degeneration and retinal vein occlusion, provided algorithms respect hemodynamic nuance instead of treating images as generic texture maps.
The most radical move, though, happens far from the clinic. Offline smartphone‑based screening pipelines now run compressed convolutional networks directly on handheld devices, flagging three major retinal diseases without cloud access and pairing camera optics with on‑device inference so a backpack kit can approximate a specialist’s triage, even where bandwidth and grid power do not exist.
Loading...
